论文部分内容阅读
本文报道40例慢性乙型肝炎患者口服干扰素随机双盲对照治疗一年,结果表明肝功能改善治疗组为50％,对照组为10％;HBSAg滴度下降,eAg转阴同时伴eAb转阳治疗组为30％,对照组为10％。其机理及扩大临床应用有待进一步研究。
This article reports 40 cases of chronic hepatitis B patients randomized double-blind controlled trial of oral interferon for one year, the results showed that the improvement of liver function was 50% in the treatment group, the control group was 10%; HBSAg titer decreased eAg negative accompanied by eAb yang The treatment group was 30% and the control group was 10%. Its mechanism and to expand clinical application needs further study.